Levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) in blood samples from different groups of adults living in Greece

Chemosphere

Volumn 80, Issue 10, 2010, Pages 1199-1206

  Vassiliadou, Irene ^a   Costopoulou, Danae ^a   Ferderigou, Angeliki ^b   Leondiadis, Leondios ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Chemical analysis; Greece; Human blood; Perfluorinated compounds; Perfluorooctanesulfonate (PFOS); Perfluorooctanoate (PFOA)

Indexed keywords

CHEMICAL ANALYSIS; CHEMICAL STABILITY; CONSUMER PRODUCTS; DISEASES;

GREECE; HUMAN BLOODS; PERFLUORINATED COMPOUNDS; PERFLUOROOCTANE SULFONATES; PERFLUOROOCTANOATE;

BLOOD;

AMPHOPHILE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ADULT; AGE CLASS; BIOACCUMULATION; BLOOD; CANCER; CONCENTRATION (COMPOSITION); DISEASE INCIDENCE; ESTER; GENDER ISSUE; POLLUTION EXPOSURE; PUBLIC HEALTH; RURAL AREA; SUBURBAN AREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CENTER; CANCER INCIDENCE; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; RURAL AREA; SEX DIFFERENCE; URBAN AREA;

ATHENS [ATTICA]; ATTICA; GREECE;

EID: 77955426092     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.06.014     Document Type: Article

References (58)

1. Ahrens, L., Xie, Z., Ebinghaus, R., in press. Distribution of perfluoralkyl compound in seawater from Northern Europe, Atlantic Ocean, and Southern Ocean. Chemosphere. doi:10.1016/j.chemosphere.2009.11.038.
2. Alexander B.H., Olsen G.W. Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann. Epidemiol. 2007, 17:471-478.
3. Becker A.M., Gerstmann S., Frank H. Perfluorooctane surfactants in waste waters, the major source of river pollution. Chemosphere 2008, 72:115-121.
4. Butenhoff J.L., Olsen G.W., Pfahles-Hutchens A. The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ. Health Perspect. 2006, 114:1776-1782. (review).
5. Butenhoff J.L., Kennedy G.L., Frame S.R., O'Connor J.C., York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 2004, 196:95-116.
6. Calafat A.M., Kuklenyik Z., Caudill S.P., Reidy J.A., Needham L.L. Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ. Sci. Technol. 2006, 40:2128-2134.
7. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Tully J.S., Needham L.L. Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES). Environ. Sci. Technol. 2007, 41:2237-2242.
8. Costopoulou D., Vassiliadou I., Papadopoulos A., Mylona A., Leondiadis L. Perfluorooctane sulphonic acid (PFOS) and perfluorooctanoic acid (PFOA) in environmental and human samples from Greece. Organohalogen Compd. 2008, 70:1681-1685.
9. Cook J.C., Murray S.M., Frame R.S., Hurtt M.E. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 1992, 1134:209-217.
10. EFSA (European Food Safety Authority) EFSA J. 2008, 653:1.
11. Ehresman D.J., Froehlich J.W., Olsen G.W., Chang S.C., Butenhoff J.L. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 2006, 103:176-184.
12. Ericson I., Gomez M., Nadal M., van Bavel B., Lindstrom G., Domingo J.L. Perfluorinated chemicals in blood residents in Catalonia (Spain) in relation to age and gender: a pilot study. Environ. Int. 2007, 33:616-623.
13. Fei C., McLaughlin J.K., Lipworth L., Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum. Reprod. 2009, 1:1-6. (Epub ahead of print).
14. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 2001, 35:1339-1342.
15. Gonzalez-Barreiro C., Martinez-Carballo E., Sitka A., Scharf S., Gans O. Method optimization for determination of selected perfluorinated alkylated substances in water samples. Anal. Bioanal. Chem. 2006, 386:2123-2132.
16. Grice M., Alexander B., Hoffbeck R., Kampa D. Self-reported medical conditions in perfluorooctanesurfonyl fluoride manufacturing workers. J. Occup. Environ. Med. 2007, 49:722-729.
17. Hansen K.J., Clemen L.A., Ellefson M.E., Johnson H.O. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 2001, 35:766-770.
18. Harada K., Inoue K., Morikawa A., Yoshinaga T., Saito T., Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanate in humans and their species-specific excretion. Environ. Res. 2005, 99:253-261.
19. Harada K., Koizumi A., Saito N., Inoue K., Yoshinaga T., Date C., Fujii S., Hachiya N., Hirosawa I., Koda S., Kusaka Y., Murata K., Omae K., Shimbo S., Takenaka K., Takeshita T., Todoriki H., Wada Y., Watanabe T., Ikeda M. Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere 2007, 66:293-301.
20. Harada K., Saito T., Inoue K., Yoshinaga T., Watanabe T., Sasaki S., et al. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanate in human serum over the last 25 years. J. Occup. Health 2004, 46:141-147.
21. Haug L., Thomsen C., Becher G. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J. Chromatogr., A 2009, 1216:385-393.
22. Haug L., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ. Sci. Technol. 2009, 43:2131-2136.
23. Jahnke A., Berger U., Ebinghaus R., Temme C. Latitudinal gradient of airborne polyfluorinated alkyl substances in the marine atmosphere between Germany and South Africa (53°N-33°S). Environ. Sci. Technol. 2007, 41:3055-3061.
24. Jensen A.A., Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int. J. Androl. 2008, 31:161-169. (review).
25. Jin Y., Saito N., Harada K.H., Inoue K., Koizumi A. Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. Tohoku J. Exp. Med. 2007, 212:63-70.
26. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Olivero J., Van Wouwe N., Yang J.H., Aldoust K.M. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 2004, 38:4489-4495.
27. Kärrman A., Mueller J.F., van Bavel B., Harden F., Toms L.M., Lindström G. Levels of 12 perfluorinated chemicals in pooled Australian serum, collected 2002-2003, in relation to age, gender, and region. Environ. Sci. Technol. 2006, 15:3742-3748.
28. Kissa E. Fluorinated Surfactants and Repellents 2001, Marcel Dekker, Inc., New York, New York. second ed.
29. Kuklenyik Z., Needham L.L., Calafat A.M. Automated solid-phase extraction approaches for large scale biomonitoring studies. Anal. Chem. 2005, 77:6085.
30. Lange, C.S., 2001. The 18-Day Aerobic Biodegradation Study of Perfluorooctanesulfonyl-Based Chemistries. Pace Analytical Services, Inc., Minneapolis, MN. US EPA Docket AR-226-1030a038. US Environmental Protection Agency, Washington, DC.
31. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
32. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198:231-241.
33. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., Strynar M.J. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol. Sci. 2006, 90:510-518.
34. Lin C.Y., Chen P.C., Lin Y.C., Lin L.Y. Association among serum perfluoroalkyl chemicals, glucose homeostasis and metabolic syndrome in adolescents and adults. Diabetes Care 2009, 32:702-708.
35. Luebker D., Hansen K.J., Bass N.M., Butenhoff J.L., Seacat A.M. Interactions of flurochemicals with rat liver fatty acid-binding protein. Toxicology 2002, 176:175-185.
36. Midasch O., Schettgen T., Angerer J. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Int. J. Hyg. Environ. Health 2006, 209:489-496.
37. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int. Arch. Occup. Environ. Health 2007, 80:643-648.
38. Organisation for Economic Co-operation and Development (OECD), 2002. Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology. Co-operation on Existing Chemicals. Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and its Salts, ENV/JM/RD(2002)17/FINAL.
39. Olivero-Verbel J., Tao L., Johnson-Restrepo B., Guette-Fernandez J., Baldiris-Avila R., O'byrne-Hoyos I., Kannan K. Perfluoroocatnesulfonate and related fluorochemicals in biological samples from the north coast of Colombia. Environ. Pollut. 2006, 142:367-372.
40. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., Boyd T.M., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., Rios J.A., Butenhoff J.L., Zobel L.R. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ. Sci. Technol. 2008, 42:4989-4995.
41. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 2009, 27:212-230.
42. Olsen G., Burris J., Ehresman D., Froehlich J., Seacat A., Butenhoff J., Zobel L. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
43. Olsen G.W., Burris J.M., Mandel J.H., Zobel L.R. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J. Occup. Environ. Med. 1999, 9:799-806.
44. Olsen G.W., Church T.R., Larson E.B., van Belle G., Lundberg J.K., Hansen K.J., Burris J.M., Mandel J.H., Zobel L.R. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 2004, 54:1599-1611.
45. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., Armitage J.B., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., O'Neill E.M., Mandel J.H., Zobel L.R. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 2003, 111:1892-1901.
46. Olsen G.W., Hansen K.J., Stevenson L.A., Burris J.M., Mandel J.H. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ. Sci. Technol. 2003, 37:888-891.
47. Olsen G.W., Huang H.Y., Helzlsouer K.J., Hansen K.J., Butenhoff J.L., Mandel J.H. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ. Health Perspect. 2005, 113:539-545.
48. Powley C., George S., Russell M., Hole R., Buck R. Polyfluorinated chemicals in a spatially and temporally integrated food web in the Western Arctic. Chemosphere 2008, 70:664-672.
49. Schultz M.M., Barovsky D.F., Field J.A. Fluorinated alkyl surfactants. Environ. Eng. Sci. 2003, 20:487-501.
50. Skutlarek D., Exner M., Faerber H. Perfluorinated surfactants in surface and drinking waters. Environ. Sci. Pollut. Res. 2006, 13:299-307.
51. Taniyasu S., Kannan K., Horii Y., Hanari N., Yamashita N. A survey of perfluorooctane sulfonate and related perfluorinated organic compounds in water, fish, birds, and humans from Japan. Environ. Sci. Technol. 2003, 15:2634-2639.
52. Tao L., Ma J., Kunisue T., Libelo E.L., Tanabe S., Kannan K. Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States. Environ. Sci. Technol. 2008, 42:8597-8602.
53. Thomford P.J., Seacat A.M., Butenhoff J.L. Terminal observations in Sprague-Dawley rats after a lifetime dietary exposure to N-ethyl perfluorooctane sulphonamide ethanol. Toxicologist 2002, 66:185.
54. Tittelmier S., Ryan J.J., Van Oostdam J. Presence of anionic perfluorinated organic compounds in serum collected from northern Canadian populations. Organohalogen Compd. 2004, 66:4009-4014.
55. Toms L.M., Calafat A.M., Kato K., Thompson J., Harden F., Hobson P., Sjödin A., Mueller J.F. Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ. Sci. Technol. 2009, 43:4194-4199.
56. Vassiliadou I., Costopoulou D., Mylona A., Leondiadis L. Perfluorooctane sulphonic acid (PFOS) and perfluorooctanoic acid (PFOA) in human blood samples from Greece. Organohalogen Compd. 2009, 71:96-99.
57. Voelkel W., Genzel-Boroviczeny O., Demmelmair H., Gebauer C., Koletzko B., Twardella D., Raab U., Fromme H. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int. J. Hyg. Environ. Health 2008, 211:440-446.
58. Wendling, L., 2003. Environmental Health and Safety Measures Relating to Perfluorooctanoic Acid and its Salts (PFOA). 3M Correspondence to US EPA Office of Prevention, Pesticides and Toxic Substances. 3M Company, St. Paul, MN. US Environmental Protection Agency Docket AR-226-1303. US Environmental Protection Agency, Washington, DC.